ArticleBMJ open2026

Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT).

Sarah Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.